Endocrinologists Providing a High Level of Expertise

Victorian Diabetes and Endocrine Network

Our Staff


Director, VDEN

Associate Professor Carolyn Allan - MBBS(Hons) PhD FRACP DRCOG (UK)

Locations: Malvern and Brighton

Usual sessions: Mon AM, Tue AM, Wed AM & PM, Fri AM (Malvern)

                          Thu AM (Brighton)

Associate Professor Carolyn Allan graduated in medicine from Monash University with honours and undertook advanced training in endocrinology at Prince Henry's Hospital/Monash Medical Centre and at St Bartholomew's Hospital in London. Whilst in the UK she completed a diploma in Obstetrics and Gynaecology. After returning to Australia in 1999 she completed a PhD in Andrology at Prince Henry's Institute (now the Hudson Institute of Medical Research). Her work has been recognised with numerous research awards and she has written chapters, reviews and editorials in leading texts and journals on the topic of testosterone disorders.

Since 2001 A/Prof Allan has been a member of Senior Medical Staff in the Departments of Endocrinology and Diabetes at Monash Health. She is the inaugural Head of the Endocrine Pregnancy Service and was previously Head of the Diabetes Pregnancy Service.

She is an Adjunct Clinical Associate Professor in the Department of Obstetrics & Gynaecology, Monash University, and at the Hudson Institute where she is the Clinical Lead in the Andrology Service.

Outside of medicine, she enjoys spending time with her husband, daughter, son and 2 dogs and is a keen soccer mum.

A/Prof Allan's practice includes diabetes and general and reproductive (male and female) endocrinology.

A/Prof Allan is the Director of the Victorian Diabetes Endocrine Network.


Yeap BB, Grossmann M, McLachlan RI, Handelsman DJ, Wittert GA, Conway AJ, Stuckey BG, Lording DW, Allan CA, Zajac JD, Burger HG. Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy. Med J Aust. Aug 15;205(4):173-8 (2016)

Yeap BB, Grossmann M, McLachlan RI, Handelsman DJ, Wittert GA, Conway AJ, Stuckey BG, Lording DW, Allan CA, Zajac JD, Burger HG. Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations. Med J Aust. Sep 5;205(5):228-31 (2016)

Hatsell BL, Allan CA, Teng J, Wong P, Ebeling PR, Wallace EM, Fuller PJ, Milat F. Management of hypoparathyroidism in pregnancy and lactation - A report of 10 cases. Bone Reports. Volume 3, December, Pages 15-19 (2015)

Allan CA, Collins VR, Frydenberg M, McLachlan RI. Androgen Deprivation Therapy Complications. Endocr Relat Cancer. Aug;21(4):T119-T129 (2014)

Stewart ZA, Wallace EM, Allan CA. Patterns of weight gain in pregnant women with and without gestational diabetes mellitus: an observational study. Aust N Z J Obstet Gynaecol 52(5):433-9 (2012).

Allan CA, Strauss BJG, Burger HG, Forbes EA, McLachlan RI. Testosterone Therapy Prevents Gain in Visceral Adipose Tissue and Loss of Skeletal Muscle in Non-Obese Aging Men. J Clin Endocrinol Metab Jan;93(1):139-146 (2008).

Yeap BB, Alfonso H, Chubb SA, Byrnes E, Beilby JP, Ebeling PR, Allan CA, Schultz C, Hankey GJ, Golledge J, Flicker L, Norman PE. Proportion of undercarboxylated osteocalcin and serum P1NP predict incidence of myocardial infarction in older men. J Clin Endocrinol Metab. 2015. 100(10) 3934-3942

Allan CA. Sex Steroids and Glucose Metabolism. Asian J Androl. Mar-Apr;16(2):232-8. (2014).

Milat F, Goh S, Gani LU, Suriadi C, Gillespie MT, Fuller PJ, Teede HJ, Strickland AH, Allan CA. Prolonged Hypocalcemia following Denosumab Therapy in Metastatic Hormone Refractory Prostate Cancer. Bone Aug;55(2):305-8 (2013).

Sartorius G, Spasevska S, Idan A, Turner L, Forbes E, Zamojska A, Allan CA, Ly LP, Conway AJ, McLachlan RI, Handelsman DJ. Serum Testosterone, Dihydrotestosterone and Estradiol Do Not Decrease with Ageing Among Men Reporting Very Good Health: The Healthy Man Study. Clin Endocrinol (Oxf). 77(5):755-763 (2012). doi: 10.1111/j.1365-2265.2012.04432.x. Epub 2012 May 7.
Allan CA, Peverill RE, Strauss BJG, Forbes EA, McLachlan RI.
Waist-to-height ratio as a predictor of serum testosterone in ageing men with symptoms of androgen deficiency. Asian J Androl. 13(3):424-431 (2011). Epub 2011 Apr 11. (IF:1.549)

Allan CA, Strauss BJG, Forbes EA, Paul E, McLachlan RI. Variability in Total Testosterone Levels in Ageing Men with Symptoms of Androgen Deficiency. International Journal of Andrology 34(3):212-216 (2011). Epub 2010 May 19. (IF:3.601)

Professional Memberships

  • Endocrine Society of Australia
  • Endocrine Society (US)
  • Society for Endocrinology (UK)
  • Women in Endocrinology (US)
  • ANZ Bone and Mineral Society
  • Australian Diabetes Society
  • Australian Medical Association
  • Australasian Diabetes in Pregnancy Society
  • Australasian Menopause Society
  • Royal Australasian College of Physicians

Professor Susan Davis - MBBS FRACP PhD FAHMS

Locations: Malvern

Usual sessions: FRI AM & PM (Malvern)

Member, VDEN

Professor Susan Davis, is an NHMRC Principal Research Fellow and Director of the Women's Health Research Program in the School of Public Health and Preventive Medicine at Monash University, Melbourne. She has over 25 years of experience in women's health research, primarily undertaking studies to progress the understanding of the roles of oestrogens and androgens in non-reproductive health including: breast cancer, cardiovascular function, obesity, cognitive function, mood, sexual function and musculoskeletal health.

Prof Davis is a Consultant Endocrinologist at Cabrini Medical Centre and the Alfred Hospital, Melbourne where she is Head, Specialist Women's Health Clinic for women with complex disease.

She is President of the International Menopause Society and a past President of the Australasian Menopause Society.

She has over 330 peer-reviewed publications and has been the recipient of a number of international research awards.

Prof Davis's specific areas of clinical expertise include menstrual disorders (such as polycystic ovarian syndrome and menstrual irregularity), menopause (including early menopause) and management of menopausal symptoms, osteoporosis and androgen (testosterone) excess and insufficiency.

She cares for women experiencing hormonal issues after treatment for cancer, particularly breast and gynaecological cancer, after organ and bone marrow transplant and women with connective tissue diseases (such as rheumatoid arthritis and lupus) treated with steroid therapy.


Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, et al. For the Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Long term effects of continuing tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS The Lancet 2013:381:805-816 Highly cited hot paper web of science.

De Villiers TJ, Pines A, Panay N, Gambacciani M, Archer DF, Baber RJ, Davis SR, Gompel AA, Henderson VW, Langer R, Lobo RA, Plu-Bureau G, Sturdee DW. International Menopause Society. Updated International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013;16(3) 316-3 Web of Science Highly Cited paper

Davis SR , Jane F, Robinson PJ, Davison SL, Worsley R*, Maruff P, Bell RJ. Transdermal Testosterone Improves Verbal Learning and Memory in Postmenopausal Women Not on Estrogen therapy. Clin Endocrinol 2014 Oct;81(4):621-8

Jane F, Davis SR. A Practitioner's Toolkit for Managing the Menopause Climacteric. 2014 Jul 6:1-16.

Robinson PJ, Bell RJ, Davis SR. Obesity is associated with a poorer prognosis in women with hormone receptor positive breast cancer Maturitas. 2014 79(3) 279-286.

Worsley R*, Jane F, Robinson RJ, Bell RJ, Davis SR. Metformin for the management of insulin resistance in overweight women at midlife: a double blind, randomised controlled trial Climacteric. 2015 Apr;18(2):270-7.

Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen JS. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline J Clin Endocrinol Metab 2015;100: 3975-4011

Gartoulla P*, Worsley R*, Bell RJ, Davis SR. Moderate-severe vasomotor and sexual symptoms remain problematic for 60-65 year old women. Menopause. 2015 Jul;22(7):694-701

Zeleke B*, Bell RJ, Billah B, Davis SR. Vasomotor and Sexual Symptoms in Older Australian Women: a Cross-Sectional Study Fertil Steril 2016 105(1): 149-155

Davis SR, Worsley R*, Miller KK, Parish SJ, Santoro N. Androgens and female sexual function and dysfunction- findings from the 4th International Consultation of Sexual Medicine. J Sex Med,2016;13 (2): 168-178


*Prof Davis's PhD student

Professional Memberships

  • International Menopause Society
  • Endocrine Society (US)
  • ANZ Bone and Mineral Society
  • Australasian Menopause Society
  • Endocrine Society of Australia
  • Australian Medical Association
  • Fellow of the Royal Australasian College of Physicians
  • North American Menopause Society
  • Fellow of the Australian Academy of Health and Medical Sciences
Member, VDEN

Dr Jasna Aleksova - MBBS (Hons) BMedSci FRACP, PhD

Locations: Malvern

Usual sessions: Wed PM (Malvern)

Dr. Jasna Aleksova graduated from the University of Melbourne and undertook her physician training at St Vincent's Hospital in Melbourne. She completed her endocrine and diabetes specialist training at Monash health and continues to have strong affiliations with both hospitals.

She completed her PhD in metabolic bone disorders and has a strong research focus on osteoporosis and bone health associated with chronic kidney disease, transplant recipients, chronic inflammatory conditions, and bone health in younger patients.

She is a post-doctoral research fellow at the Hudson Institute for Medical Research and Monash University with ongoing research in reproductive hormones and musculoskeletal health. Her work has been highly regarded and she has been the recipient of numerous research awards.

Dr. Aleksova is a senior staff specialist in the metabolic bone clinics at St Vincent's hospital, Monash Health and the Alfred hospital. She also works in the specialised diabetes services and additionally has an interest in endocrine conditions associated with pregnancy, working in a dedicated endocrine & pregnancy service at Monash Health.

In her clinical practice at Malvern she consults on all aspects of diabetes and general endocrinology.

Outside of work Dr. Aleksova enjoys her yoga practice, spending time with her friends and family, travelling, trying new culinary experiences and jogging with her dog.


Aleksova J, Milat F, Kotowicz MA, Pasco JA, Schultz C, Wong P, Ebeling PR, Elder GJ. Patients with end-stage kidney disease have markedly abnormal cortical hip parameters by dual-energy X-ray absorptiometry. Nephrol Dial Transplant. 2019 Nov 7

Aleksova J, Rodriguez AJ, McLachlan R, Milat F, Ebeling PR. Gonadal Hormones in the Pathogenesis and Treatment of Bone Health in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Current Osteoporosis Reports. Accepted for publication.

Aleksova J, Ng KW, Jung C, Zeimer H, Dwyer K, Milat F, MacIsaac R. Bone Health in Chronic Kidney Disease-Mineral and Bone Disorder: A Clinical Case Seminar and Update. Internal Medicine Journal. Accepted for publication.

Aleksova J, Kurniawan S, Vucak-Dzumhur M, Kerr P, Ebeling PR, Milat F, Elder GJ. Aortic vascular calcification is inversely associated with the trabecular bone score in patients receiving dialysis. Bone. 2018 Aug;113:118-123. doi: 10.1016/j.bone.2018.05.014.

Aleksova J, Wong P, McLachlan R, Choy KW, Ebeling PR, Milat F, Elder G. Sex Hormone Binding Globulin as a Risk Factor for Non-Vertebral Fracture in Men on Dialysis Therapy. Kidney International. 2018 Aug;94(2):372-380. doi: 10.1016/j.kint.2018.02.021.

Aleksova J, Kurniawan S and Elder GJ (2018). The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease. Osteoporosis International.  2018 Jun;29(6):1447-1455. doi: 10.1007/s00198-018-4468-y.

Aleksova J, Wong P, Mulley W, Choy KW, McLachlan R, Ebeling PR, Kerr P, Milat F. Serum phosphorus levels and fracture following renal transplantation. Clinical Endocrinology (Oxf). 2017 Aug;87(2):141-148. doi: 10.1111/cen.13363.

Aleksova J, Wong P, Milat F. Management of Bone Health in Patients with Chronic Disease. Endocrinology Today. July 2017.

Aleksova J, Kuczynska-Burggraf M, Ranasinha S, Vincent A. Information on early menopause: is the internet the place to search? Climacteric. 2017 Jun;20(3):248-255. doi: 10.1080/13697137.2017.1301920.

Aleksova J, Lau P, Soldatos G, MacArthur G. Glucocorticoids Did Not Reverse Type 1 Diabetes Mellitus Secondary to Pembrolizumab in a Patient with Metastatic Melanoma. The British Medical Journal Case reports. 2016 Nov 23;2016. pii: bcr2016217454. doi: 10.1136/bcr-2016-217454.

Aleksova J, Glenn Ward, Kim Taubman, Jason Tan, Stephen Farrell, Stuart Galloway, Richard J MacIsaac, Nirupa Sachithanandan. A Cushing’s Conundrum: An Unusual Case of Primary Pigmented Nodular Adrenal Disease in a 60 year old Female. The Lancet Diabetes & Endocrinology. 2016 Jul;4(7):630. doi: 10.1016/S2213-8587(15)00262-4.

Aleksova J, Jung C, 2015. Addison’s disease: a diagnosis not to be missed. Endocrinology Today; 4(1): 23-28.

Aleksova J, Allan CA, 2013. An update in testosterone replacement therapies. Endocrinology Today; 2(2): 19-22

Professional Memberships

  • Endocrine Society of Australia
  • Endocrine Society (USA)
  • Australian Diabetes Society
  • Australia and New Zealand Bone and Mineral society
  • American Society for Bone and Mineral Research
  • Fellow of the Royal Australasian College of Physicians

Dr Dilan Seneviratne Epa - Endocrinologist MBBS FRACP

Usual sessions

Tues PM (Malvern)
Wed PM (WMS Malvern- Forthnightly)
Thurs PM (Hawthorn East- Forthnightly)
Thurs AM & PM (Leongatha- Monthly).

Director, VDEN

Dr Dilan Seneviratne Epa undertook advanced training in Endocrinology at St Vincent’s and Alfred Hospitals in Melbourne. Having obtained his medical degree with honours in 2011, Dr Seneviratne Epa received a full grant from the European Association for the Study of Diabetes to attend the Robert Turner Clinical Research Course at the Oxford Centre for Diabetes Endocrinology and Metabolism in the UK.

He has published research in leading international peer-reviewed journals, and presented at international conferences.

He has also contributed to the development and review of clinical practice guidelines at the hospitals he has worked at and continues to engage in quality improvement. He is actively involved in teaching medical students from Monash and Melbourne Universities and also physician trainees.

Dr Dilan Seneviratne Epa is an Endocrinologist with an interest in treating diabetes mellitus, osteoporosis, thyroid, pituitary, adrenal, reproductive (male and female) and general endocrine disorders. His dual training in General Medicine and Endocrinology makes him uniquely placed to manage multiple complex medical problems associated with chronic disease such as the sequelae associated with diabetes mellitus.

Outside of medicine he enjoys playing cricket and going on road trips with his family.



Hamblin PS, Wong R, Ekinci EI, Fourlanos S, Shah S, Jones AR, Hare MJL, Calder GL, Seneviratne Epa D et al. SGLT2 Inhibitors
Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission. J Clin Endocrinol Metab. 2019 Aug 1;104(8):3077-3087.

Seneviratne Epa D, Ng E, Schneider HG, Nagalingam V, Bach LA, Sztal‐Mazer S.
Prevalence of hyperglycaemia without previously recognised diabetes mellitus in the Emergency Department and subsequent management – A retrospective cross‐sectional study. Intern Med J. 1 Nov 2020, 50(11):1397-1403.

Seneviratne Epa D, Maggie Moore, Sztal‐Mazer S.
A complex case of permanent hypoadrenalism with high dose glucocorticoid (HDGC) use for immune related adverse events (irAEs) of checkpoint inhibitors. Clinical Endocrinology, 89 (Suppl. 1): 80, Jun 2018

Seneviratne Epa D, Mathew RR, Miriam DNADR, Lamabadusuriya DA, Ekanayake R, Narenthiran S, Caldera R, Ranasinghe P, Liyanage IK, Amarasena GAC, Matthew DR, Katulanda P.
The effect of coronary revascularization on the quality of life in patients with ischaemic heart disease. The Ceylon Medical Journal, Vol 56 (Suppl. 1):20, Jun 2011

Seneviratne Epa D, Samaraweera DI, Somasundaram N.
Quality of foot care at diabetic clinic of National Hospital of Sri Lanka. Journal of the Ruhunu Clinical Society. 2010; 17: 5-11.

Seneviratne Epa D, Shalini M, Shyanth S, Jayawardane A.
Prevalence and associated factors for obesity and overweight among school children. Journal of the Ruhunu Clinical Society. 2009; 16: 8-14.

Member, VDEN

Dr John Colman - Gastroenterologist - MBBS FRACP

Location: Malvern 

Usual sessions: Mon PM, Wed AM, Thu PM

Dr John Colman is a Gastroenterologist and a senior Consultant at VDEN.  He has supported VDEN from it inception.  

He holds a current appointment at The Alfred Hospital.

Currently he is practising at Cabrini Malvern as well as The Alfred and Springvale sites with VDEN Malvern acting as his princial office.  


John is one of the leading Gastroenterologists in the field of Medico Legal Consulting.

John also has an active social life which includes a number of clubs as well as his new dog.

Allied Health Professionals

Please contact us on (03) 9509 9411 or email us on info@vden.com.au for further information regarding appointments with our Diabetes Nurse Educator.

Sue Wyatt - Credentialled Diabetes Nurse Educator RN 

Locations: Malvern

Usual sessions: Fri PM; Mon AM (Malvern - By Appointment)

Sue Wyatt has been a Diabetes Educator for 29 years, working in both the public and private sector. She was the Diabetes Education Manager at Alfred Health for 12 years, and prior to that, the Lead Diabetes Educator at Monash Health.

She is a past secretary of the Australian Diabetes Educators Association and an assessor for the Deakin University Diabetes Education Course.

Sue is a Certified Inuslin Pump Trainer and is an expert in all forms of Continuous Glucose Monitoring. She is the Research Nurse Co-ordinator for the Hybrid Closed Loop Insulin Pump Study being conducted by Melbourne University.

Sue's passions are the managment of Type 1 Diabetes utilising technological advances in pump therapy and continuous glucose monitoring, and optimising pregnancy outcomes for women with Type 1 and Type 2 Diabetes and Gestational Diabetes Mellitus.

She is a strong advocate for Telehealth and is practising via Zoom consultations in the COVID-19 environment.



For further information please contact us:

General Enquiries

Tel: (03) 9509 9411
E-mail: info@vden.com.au

To schedule appointments, click HERE